Introduction to Advances In Testing A Personalized Ctdna Assay For Mrd Detection And Surveillance
Let's dive into the details surrounding Advances In Testing A Personalized Ctdna Assay For Mrd Detection And Surveillance. Presenter: Dr. Alexey Aleshin, Sr Medical Director, Oncology, Natera.
Advances In Testing A Personalized Ctdna Assay For Mrd Detection And Surveillance Comprehensive Overview
This talk was presented by Michael Krainock during the “ET: The Next Big Thing” session at the SAGES 2021 Annual Meeting on ... Natera - 2021 CGC Virtual Annual Meeting. The Cancer Genomics Consortium (CGC - https://cancergenomics.org/) represents a ... 0:00 - 1:31:
Hiromichi Shirasu, MD, Shizuoka Cancer Center, Shizuoka, Japan, discusses findings of a molecular subgroup analysis of the ...
Summary & Highlights for Advances In Testing A Personalized Ctdna Assay For Mrd Detection And Surveillance
- Andrew A. Davis, MD, Washington University School of Medicine, St. Louis, MOm discusses future approaches in the use of ...
- As a longtime patient advocate, Meryl Weinreb has witnessed the evolution of breast cancer screening and treatment over the ...
- Presented Alexey Aleshin, MD, Senior Medical Director Oncology, Natera.
- In this video, Vincent Camus, MD, Centre Henri Becquerel & LYSA Group Member, Rouen, France, shares insights into a ...
- Important Note: This video is for your information only. Do not use these videos for medical advice,
That wraps up our extensive overview of Advances In Testing A Personalized Ctdna Assay For Mrd Detection And Surveillance.